Press Releases

 
Press Releases
  Date Title and Summary View
Feb 22, 2012
AMES, Iowa, Feb. 22, 2012 (GLOBE NEWSWIRE) -- NewLink Genetics (Nasdaq:NLNK) announced today that Dr. Charles Link, Chairman and CEO, will participate in a panel discussion at the 2012 RBC Capital Markets Global Healthcare Conference on Wednesday, February 29, 2012 at 11 a.m. Eastern time in New York, NY. The panel will be moderated by Dr. Jason Ka...
Nov 11, 2011
AMES, Iowa, Nov. 11, 2011 (GLOBE NEWSWIRE) -- NewLink Genetics Corporation (Nasdaq:NLNK) announced today the initial public offering of 6,200,000 shares of its common stock at a price of $7.00 per share. The common stock is expected to begin trading on the NASDAQ Global Market on November 11, 2011 under the trading symbol "NLNK." NewLink has grante...
Oct 7, 2011
AMES, Iowa, Oct. 7, 2011 (GLOBE NEWSWIRE) -- NewLink Genetics Corporation, a privately held biopharmaceutical company, today announces that Mr. Paul R. Edick was appointed as a director of NewLink Genetics Corporation. Mr. Edick is a pharmaceutical industry veteran with over 30 years of experience in international pharmaceuticals, venture capita...
May 31, 2011
AMES, Iowa, May 31, 2011 (GLOBE NEWSWIRE) -- NewLink Genetics Corporation today announced that data from its investigational HyperAcute® Prostate cancer immunotherapy and investigational HyperAcute® Melanoma immunotherapy clinical trials will be presented at the American Society of Clinical Oncology (ASCO) 2011 Annual Meeting to be held J...
Apr 1, 2011
AMES, Iowa, April 1, 2011 (GLOBE NEWSWIRE) -- NewLink Genetics Corporation today announced that additional data from its Phase 2 clinical trial of the Company's investigational HyperAcute® Lung cancer immunotherapy will be presented during a poster session at the American Association for Cancer Research 102nd Annual Meeting 2011 in ...
Page: FirstPrevious ...
18
= add release to Briefcase